-
1581
Editorial: Emerging and re-emerging viral infections: epidemiology, pathogenesis and new methods for control and prevention
Published 2025-01-01Subjects: Get full text
Article -
1582
-
1583
Medicinal products used for the treatment and prophylaxis of COVID-19
Published 2020-06-01Subjects: Get full text
Article -
1584
Editorial: Antigen presentation in cancer immune responses
Published 2025-01-01Subjects: Get full text
Article -
1585
Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
1586
-
1587
Corrigendum: Making sense of a pandemic: reasoning about COVID-19 in the intellectual dark web
Published 2025-01-01Subjects: Get full text
Article -
1588
Making sense of a pandemic: reasoning about COVID-19 in the intellectual dark web
Published 2024-09-01Subjects: Get full text
Article -
1589
Risk of hospitalization of diagnosed COVID-19 cases during the pandemic: A time-series analysis to unveil short- and long-run dynamics
Published 2024-03-01Subjects: Get full text
Article -
1590
Recruitment of Young Gay, Bisexual, and Other Men Who Have Sex With Men for a Web-Based Human Papillomavirus Vaccination Intervention: Differences in Participant Characteristics and Study Engagement by Recruitment Source in a Randomized Controlled Trial
Published 2025-01-01“…These participants also spent a longer amount of time viewing intervention content about HPV vaccination (3.14 minutes vs 2.67 minutes; P=.02). …”
Get full text
Article -
1591
Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia
Published 2023-09-01“…Introduction People who are immunocompromised have a poor biological response to vaccinations. This study aims to determine in patients with chronic lymphocytic leukaemia (CLL) if a 3-week pause in Bruton tyrosine kinase inhibitor therapy (BTKi) starting 1 week before delivery of SARS-CoV-2 vaccine booster, improves vaccine immune response when compared with continuation of BTKi.Methods and analysis An open-label, randomised controlled superiority trial will be conducted in haematology clinics in approximately 10 UK National Health Service (NHS) hospitals. …”
Get full text
Article -
1592
Studies on development of early immunity against type O FMD in naturally susceptible animals
Published 2020-06-01Subjects: “…inactivated monovalent emulsion vaccine…”
Get full text
Article -
1593
-
1594
-
1595
Affordable mRNA Novel Proteins, Recombinant Protein Conversions, and Biosimilars—Advice to Developers and Regulatory Agencies
Published 2025-01-01Subjects: Get full text
Article -
1596
Impact of Obesity-Associated SARS-CoV-2 Mutations on COVID-19 Severity and Clinical Outcomes
Published 2024-12-01Subjects: Get full text
Article -
1597
-
1598
A HABA dye-based colorimetric assay to detect unoccupied biotin binding sites in an avidin-containing fusion protein
Published 2024-10-01Subjects: Get full text
Article -
1599
CLINICAL IMMUNOLOGY AND ALLERGOLOGY AS AN IMPORTANT COMPONENT OF CONTINUOUS MEDICAL EDUCATION OF DOCTORS
Published 2022-12-01Subjects: Get full text
Article -
1600
Autoimmune/autoinflammatory syndrome induced by adjuvants: what is it and why the controversy?
Published 2019-01-01Subjects: Get full text
Article